Article Information
Published By
Online ISSN
History
- Received September 13, 2022
- Accepted October 3, 2022
- Published online November 10, 2022.
Article Versions
- You are currently viewing a previous version of this article (November 10, 2022 - 09:01).
- View the most recent version of this article
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- J Gerry Coghlan1⇑,
- Sean Gaine2,
- Richard Channick3,
- Kelly M Chin4,
- Camille du Roure5,
- J Simon R Gibbs6,
- Marius M Hoeper7,
- Irene M Lang8,
- Stephen C Mathai9,
- Vallerie V McLaughlin10,
- Lada Mitchell5,
- Gérald Simonneau11,
- Olivier Sitbon11,
- Victor F Tapson12 and
- Nazzareno Galiè13
- 1Royal Free Hospital, London, UK
- 2Mater Misericordiae University Hospital, Dublin, Ireland
- 3David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
- 4UT Southwestern Medical Center, Dallas, TX, USA
- 5Actelion Pharmaceuticals Ltd, a Janssen Pharmaceutical Company of Johnson & Johnson, Allschwil, Switzerland
- 6National Heart & Lung Institute, Imperial College London, London, UK
- 7Department of Respiratory Medicine, Hannover Medical School and German Center for Lung Research, Hannover, Germany
- 8Division of Cardiology, Medical University of Vienna, Vienna
- 9Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 10University of Michigan, Ann Arbor, MI, USA
- 11Hôpital Bicêtre, Université Paris-Sud, Le Kremlin Bicêtre, France
- 12Cedars-Sinai Medical Center, Los Angeles, CA, USA
- 13Alma Mater Studiorum, University of Bologna and IRCCS-S.Orsola University Hospital, Bologna, Italy
- Corresponding author: John Coghlan (gerry.coghlan{at}nhs.net)
Funding
Actelion Pharmaceuticals
Article usage
Altmetrics
Vol 9 Issue 1
Table of Contents
Early selexipag initiation and long-term outcomes: Insights from RCTs in PAH
